Broad targeting of angiogenesis for cancer prevention and therapy

Ribatti, 2012, Intussusceptive microvascular growth in tumors, Cancer Lett, 316, 126, 10.1016/j.canlet.2011.10.040 Cao, 2011, Forty-year journey of angiogenesis translational research, Sci Transl Med, 3, 114rv113, 10.1126/scitranslmed.3003149 Folkman, 1971, Tumor angiogenesis: therapeutic implications, N Engl J Med, 285, 1182, 10.1056/NEJM197111182852108 Bergers, 2008, Modes of resistance to anti-angiogenic therapy, Nat Rev Cancer, 8, 592, 10.1038/nrc2442 Ribatti, 2009, Endogenous inhibitors of angiogenesis: a historical review, Leuk Res, 33, 638, 10.1016/j.leukres.2008.11.019 Landskroner-Eiger, 2013, miRNAs as modulators of angiogenesis, Cold Spring Harb Perspect Med, 3, a006643, 10.1101/cshperspect.a006643 Hellstrom, 2007, Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis, Nature, 445, 776, 10.1038/nature05571 Siekmann, 2007, Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries, Nature, 445, 781, 10.1038/nature05577 Jakobsson, 2010, Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting, Nat Cell Biol, 12, 943, 10.1038/ncb2103 Krueger, 2011, Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo, Development, 138, 2111, 10.1242/dev.063933 Ridgway, 2006, Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis, Nature, 444, 1083, 10.1038/nature05313 Noguera-Troise, 2006, Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis, Nature, 444, 1032, 10.1038/nature05355 Nagy, 2012, Vascular hyperpermeability, angiogenesis, and stroma generation, Cold Spring Harb Perspect Med, 2, a006544, 10.1101/cshperspect.a006544 Xue, 2012, PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells, Nat Med, 18, 100, 10.1038/nm.2575 Hosaka, 2013, Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis, Nat Commun, 4, 2129, 10.1038/ncomms3129 Hedlund, 2013, Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs, Proc Natl Acad Sci U S A, 110, 654, 10.1073/pnas.1209310110 van der Schaft, 2004, Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells, J Natl Cancer Inst, 96, 1473, 10.1093/jnci/djh267 Nagy, 2012, Heterogeneity of the tumor vasculature: the need for new tumor blood vessel type-specific targets, Clin Exp Metastasis, 29, 657, 10.1007/s10585-012-9500-6 Jain, 2005, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, 307, 58, 10.1126/science.1104819 Shanmugam, 2014, Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence, Cancer Lett, 346, 206, 10.1016/j.canlet.2014.01.016 Bruick, 2001, A conserved family of prolyl-4-hydroxylases that modify HIF, Sci Signal, 294, 1337 Maxwell, 1999, The tumour suppressor protein VHL targets hypoxia inducible factors for oxygen-dependent proteolysis, Nature, 399, 271, 10.1038/20459 Raval, 2005, Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel–Lindau-associated renal cell carcinoma, Mol Cell Biol, 25, 5675, 10.1128/MCB.25.13.5675-5686.2005 Hu, 2003, Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation, Mol Cell Biol, 23, 9361, 10.1128/MCB.23.24.9361-9374.2003 Iliopoulos, 1996, Negative regulation of hypoxia-inducible genes by the von Hippel–Lindau protein, Proc Natl Acad Sci U S A, 93, 10595, 10.1073/pnas.93.20.10595 Tosetti, 2002, Angioprevention: angiogenesis is a common and key target for cancer chemopreventive agents, FASEB J, 16, 2, 10.1096/fj.01-0300rev Ivan, 2008, Hypoxia response and microRNAs: no longer two separate worlds, J Cell Mol Med, 12, 1426, 10.1111/j.1582-4934.2008.00398.x Kaelin, 2004, The von Hippel–Lindau tumor suppressor gene and kidney cancer, Clin Cancer Res, 10, 6290S, 10.1158/1078-0432.CCR-sup-040025 Leong, 2006, Clinical patterns of metastasis, Cancer Metastasis Rev, 25, 221, 10.1007/s10555-006-8502-8 Sleeman, 2000, The lymph node as a bridgehead in the metastatic dissemination of tumors, Recent Results Cancer Res, 157, 55, 10.1007/978-3-642-57151-0_6 Bono, 2004, High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer, Clin Cancer Res, 10, 7144, 10.1158/1078-0432.CCR-03-0826 Nakamura, 2005, Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer, Breast Cancer Res Treat, 91, 125, 10.1007/s10549-004-5783-x Gombos, 2005, Peritumoral lymphatic vessel density and vascular endothelial growth factor C expression in early-stage squamous cell carcinoma of the uterine cervix, Clin Cancer Res, 11, 8364, 10.1158/1078-0432.CCR-05-1238 Chen, 2007, Study on the relationship between lymphatic vessel density and distal intramural spread of rectal cancer, Eur Surg Res, 39, 332, 10.1159/000104837 Renyi-Vamos, 2005, Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer, Clin Cancer Res, 11, 7344, 10.1158/1078-0432.CCR-05-1077 Padera, 2002, Lymphatic metastasis in the absence of functional intratumor lymphatics, Science, 296, 1883, 10.1126/science.1071420 Wang, 2010, Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases, BMC Cancer, 10, 299, 10.1186/1471-2407-10-299 Ravindranath, 2004, Anticancer therapeutic potential of soy isoflavone, genistein, Adv Exp Med Biol, 546, 121, 10.1007/978-1-4757-4820-8_11 Mattila, 2002, VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors, Int J Cancer, 98, 946, 10.1002/ijc.10283 Karpanen, 2001, Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth, Cancer Res, 61, 1786 Ochi, 2007, Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis, Pancreas, 34, 444, 10.1097/mpa.0b13e31803dd307 Skobe, 2001, Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis, Nat Med, 7, 192, 10.1038/84643 Mumprecht, 2009, Lymphangiogenesis and cancer metastasis, J Cell Mol Med, 13, 1405, 10.1111/j.1582-4934.2009.00834.x Ran, 2010, Lymphangiogenesis and lymphatic metastasis in breast cancer, Pathophysiology, 17, 229, 10.1016/j.pathophys.2009.11.003 Chang, 2004, Dose-dependent response of FGF-2 for lymphangiogenesis, Proc Natl Acad Sci U S A, 101, 11658, 10.1073/pnas.0404272101 Kubo, 2002, Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea, Proc Natl Acad Sci U S A, 99, 8868, 10.1073/pnas.062040199 Zhou, 2003, Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice, J Nutr, 133, 516, 10.1093/jn/133.2.516 Kajiya, 2005, Hepatocyte growth factor promotes lymphatic vessel formation and function, EMBO J, 24, 2885, 10.1038/sj.emboj.7600763 Zhou, 2004, Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice, Int J Cancer, 108, 8, 10.1002/ijc.11549 Li, 2011, Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45, Cancer, 117, 3135, 10.1002/cncr.25893 Makinen, 2005, PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature, Genes Dev, 19, 397, 10.1101/gad.330105 Helfrich, 2009, Angiopoietin-2 levels are associated with disease progression in metastatic malignant melanoma, Clin Cancer Res, 15, 1384, 10.1158/1078-0432.CCR-08-1615 Cao, 2004, PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis, Cancer Cell, 6, 333, 10.1016/j.ccr.2004.08.034 Banziger-Tobler, 2008, Growth hormone promotes lymphangiogenesis, Am J Pathol, 173, 586, 10.2353/ajpath.2008.080060 Hirakawa, 2005, VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis, J Exp Med, 201, 1089, 10.1084/jem.20041896 Hirakawa, 2007, VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites, Blood, 109, 1010, 10.1182/blood-2006-05-021758 Ishii, 2010, Primary tumor induces sentinel lymph node lymphangiogenesis in oral squamous cell carcinoma, Oral Oncol, 46, 373, 10.1016/j.oraloncology.2010.02.014 Christiansen, 2011, Lymphangiogenesis and cancer, Genes Cancer, 2, 1146, 10.1177/1947601911423028 Alitalo, 2011, The lymphatic vasculature in disease, Nat Med, 17, 1371, 10.1038/nm.2545 Fukumura, 2007, Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize, J Cell Biochem, 101, 937, 10.1002/jcb.21187 Duong, 2012, Tumor lymphangiogenesis as a potential therapeutic target, J Oncol, 204946 Roenneberg, 2013, Chronobiology: the human sleep project, Nature, 498, 427, 10.1038/498427a Jensen, 2013, Clock controls angiogenesis, Cell Cycle, 12, 405, 10.4161/cc.23596 Jensen, 2012, Opposing effects of circadian clock genes bmal1 and period2 in regulation of VEGF-dependent angiogenesis in developing zebrafish, Cell Rep, 2, 231, 10.1016/j.celrep.2012.07.005 Schernhammer, 2003, Night-shift work and risk of colorectal cancer in the nurses’ health study, J Natl Cancer Inst, 95, 825, 10.1093/jnci/95.11.825 Schernhammer, 2001, Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study, J Natl Cancer Inst, 93, 1563, 10.1093/jnci/93.20.1563 Rao, 2013, A direct and melanopsin-dependent fetal light response regulates mouse eye development, Nature, 494, 243, 10.1038/nature11823 Busik, 2009, Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock, J Exp Med, 206, 2897, 10.1084/jem.20090889 Anea, 2012, Increased superoxide and endothelial NO synthase uncoupling in blood vessels of Bmal1-knockout mice, Circ Res, 111, 1157, 10.1161/CIRCRESAHA.111.261750 Wang, 2008, Increased vascular senescence and impaired endothelial progenitor cell function mediated by mutation of circadian gene Per2, Circulation, 118, 2166, 10.1161/CIRCULATIONAHA.108.790469 Koyanagi, 2003, A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells, Cancer Res, 63, 7277 Guzy, 2006, Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia, Exp Physiol, 91, 807, 10.1113/expphysiol.2006.033506 Denko, 2008, Hypoxia, HIF1 and glucose metabolism in the solid tumour, Nat Rev Cancer, 8, 705, 10.1038/nrc2468 Gillies, 2012, Evolutionary dynamics of carcinogenesis and why targeted therapy does not work, Nat Rev Cancer, 12, 487, 10.1038/nrc3298 Ferrara, 2010, Role of myeloid cells in vascular endothelial growth factor-independent tumor angiogenesis, Curr Opin Hematol, 17, 219 Apte, 2006, Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour–host interactions, Eur J Cancer, 42, 751, 10.1016/j.ejca.2006.01.010 Nicolini, 2006, Cytokines in breast cancer, Cytokine Growth Factor Rev, 17, 325, 10.1016/j.cytogfr.2006.07.002 Crawford, 2009, PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment, Cancer Cell, 15, 21, 10.1016/j.ccr.2008.12.004 Ricci-Vitiani, 2010, Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells, Nature, 468, 824, 10.1038/nature09557 Maione, 2012, Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice, J Clin Invest, 122, 1832, 10.1172/JCI58976 Paez-Ribes, 2009, Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis, Cancer Cell, 15, 220, 10.1016/j.ccr.2009.01.027 Ebos, 2009, Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis, Cancer Cell, 15, 232, 10.1016/j.ccr.2009.01.021 Lu, 2012, VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex, Cancer Cell, 22, 21, 10.1016/j.ccr.2012.05.037 Jensen, 2009, In vivo angiogenesis and lymphangiogenesis models, Curr Mol Med, 9, 982, 10.2174/156652409789712738 Jensen, 2011, Zebrafish models to study hypoxia-induced pathological angiogenesis in malignant and nonmalignant diseases, Birth Defects Res C Embryo Today, 93, 182, 10.1002/bdrc.20203 Willett, 2004, Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer, Nat Med, 10, 145, 10.1038/nm988 Lockhart, 2010, Phase I study of intravenous vascular endothelial growth factor trap, aflibercept, in patients with advanced solid tumors, J Clin Oncol, 28, 207, 10.1200/JCO.2009.22.9237 Zhong, 2000, Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics, Cancer Res, 60, 1541 Mabjeesh, 2002, Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells, Cancer Res, 62, 2478 Gotink, 2010, Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?, Angiogenesis, 13, 1, 10.1007/s10456-009-9160-6 Mihaly, 2012, A comprehensive overview of targeted therapy in metastatic renal cell carcinoma, Curr Cancer Drug Targets, 12, 857, 10.2174/156800912802429265 Grothey, 2013, Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial, Lancet, 381, 303, 10.1016/S0140-6736(12)61900-X Yashiro, 2009, Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model, Br J Cancer, 101, 1100, 10.1038/sj.bjc.6605296 Penel, 2012, Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?, Crit Rev Oncol Hematol, 82, 40, 10.1016/j.critrevonc.2011.04.009 Kerbel, 2011, Reappraising antiangiogenic therapy for breast cancer, Breast, 20, S56, 10.1016/S0960-9776(11)70295-8 Miller, 2001, Redefining the target: chemotherapeutics as antiangiogenics, J Clin Oncol, 19, 1195, 10.1200/JCO.2001.19.4.1195 Klauber, 1997, Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol, Cancer Res, 57, 81 Browder, 2000, Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer, Cancer Res, 60, 1878 Singhal, 1999, Antitumor activity of thalidomide in refractory multiple myeloma, N Engl J Med, 341, 1565, 10.1056/NEJM199911183412102 Wood, 2002, Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid, J Pharmacol Exp Ther, 302, 1055, 10.1124/jpet.102.035295 Santini, 2003, Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients, Clin Cancer Res, 9, 2893 Land, 2007, Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif, J Biol Chem, 282, 20534, 10.1074/jbc.M611782200 Hudson, 2002, Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin, Mol Cell Biol, 22, 7004, 10.1128/MCB.22.20.7004-7014.2002 Guba, 2002, Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor, Nat Med, 8, 128, 10.1038/nm0202-128 Zhang, 2011, Antiangiogenic agents significantly improve survival in tumor-bearing mice by increasing tolerance to chemotherapy-induced toxicity, Proc Natl Acad Sci U S A, 108, 4117, 10.1073/pnas.1016220108 Singh, 2009, Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from Acacia nilotica bark, Chem Biol Interact, 181, 20, 10.1016/j.cbi.2009.05.007 Singh, 2014, Dietary phytochemicals alter epigenetic events and signaling pathways for inhibition of metastasis cascade: phytoblockers of metastasis cascade, Cancer Metastasis Rev, 33, 41, 10.1007/s10555-013-9457-1 Singh, 2011, Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications, Biochem Pharmacol, 82, 1807, 10.1016/j.bcp.2011.07.093 Gullett, 2010, Cancer prevention with natural compounds, Semin Oncol, 37, 258, 10.1053/j.seminoncol.2010.06.014 Singh, 2012, New strategies in cancer chemoprevention by phytochemicals, Front Biosci (Elite Ed), 4, 426, 10.2741/e389 Bishayee, 2012, Editorial: current advances in cancer prevention and treatment by natural products, Curr Pharm Biotechnol, 13, 115, 10.2174/138920112798868629 Jeong, 2013, Studies on lymphangiogenesis inhibitors from Korean and Japanese crude drugs, Biol Pharm Bull, 36, 152, 10.1248/bpb.b12-00871 Kimura, 2013, Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis, Phytomedicine, 20, 328, 10.1016/j.phymed.2012.10.016 Luo, 2011, Cryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathways, Cancer Prev Res (Phila), 4, 2083, 10.1158/1940-6207.CAPR-11-0319 Coussens, 2002, Cancer therapy – matrix metalloproteinase inhibitors and cancer: trials and tribulations, Science, 295, 2387, 10.1126/science.1067100 Bendrik, 2008, Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo, Cancer Res, 68, 3405, 10.1158/0008-5472.CAN-08-0295 Hamano, 2003, Physiological levels of tumstatin, a fragment of collagen IV alpha 3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alpha V beta 3 integrin, Cancer Cell, 3, 589, 10.1016/S1535-6108(03)00133-8 Nilsson, 2006, Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo, Cancer Res, 66, 4789, 10.1158/0008-5472.CAN-05-4012 Pozzi, 2002, Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis, Oncogene, 21, 272, 10.1038/sj.onc.1205045 Decock, 2011, Matrix metalloproteinases: protective roles in cancer, J Cell Mol Med, 15, 1254, 10.1111/j.1582-4934.2011.01302.x Leifler, 2013, Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer, J Immunol, 190, 4420, 10.4049/jimmunol.1202610 Partridge, 2007, Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis, J Biol Chem, 282, 35964, 10.1074/jbc.M705993200 Kopitz, 2007, Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling, Cancer Res, 67, 8615, 10.1158/0008-5472.CAN-07-0232 Lipton, 2007, Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer, Cancer, 109, 1933, 10.1002/cncr.22637 Miyagi, 2007, The TIMP-1 gene transferred through adenovirus mediation shows a suppressive effect on peritoneal metastases from gastric cancer, Int J Clin Oncol, 12, 17, 10.1007/s10147-006-0616-z Klintman, 2010, Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer, Breast Cancer Res Treat, 121, 365, 10.1007/s10549-009-0483-1 Schrohl, 2003, Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer, Mol Cell Proteomics, 2, 164, 10.1074/mcp.M300019-MCP200 Schrohl, 2009, Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: a retrospective study, BMC Cancer, 9, 10.1186/1471-2407-9-322 Stanley, 2005, Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells, Biochem Biophys Res Commun, 330, 46, 10.1016/j.bbrc.2005.02.116 Brakenhielm, 2001, Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes, FASEB J, 15, 1798, 10.1096/fj.01-0028fje Huang, 1999, Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor, Br J Pharmacol, 128, 999, 10.1038/sj.bjp.0702879 Tosetti, 2002, The angiogenic switch in solid tumors: clinical implications, Suppl Tumori, 1, S9, 10.1177/03008916020016s103 Cao, 1999, Angiogenesis inhibited by drinking tea, Nature, 398, 381, 10.1038/18793 Sartippour, 2002, Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells, J Nutr, 132, 2307, 10.1093/jn/132.8.2307 Maeda-Yamamoto, 1999, Effects of tea polyphenols on the invasion and matrix metalloproteinases activities of human fibrosarcoma HT1080 cells, J Agric Food Chem, 47, 2350, 10.1021/jf9811525 Ramos, 2007, Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention, J Nutr Biochem, 18, 427, 10.1016/j.jnutbio.2006.11.004 Yang, 2010, Antitumor activity of novel fluoro-substituted (−)-epigallocatechin-3-gallate analogs, Cancer Lett, 292, 48, 10.1016/j.canlet.2009.11.006 Slivova, 2005, Green tea polyphenols modulate secretion of urokinase plasminogen activator (uPA) and inhibit invasive behavior of breast cancer cells, Nutr Cancer, 52, 66, 10.1207/s15327914nc5201_9 Sen, 2009, Multifunctional effect of epigallocatechin-3-gallate (EGCG) in downregulation of gelatinase-A (MMP-2) in human breast cancer cell line MCF-7, Life Sci, 84, 194, 10.1016/j.lfs.2008.11.018 Lin, 1999, Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade, Biochem Pharmacol, 58, 911, 10.1016/S0006-2952(99)00112-4 Jung, 2001, EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells, Br J Cancer, 84, 844, 10.1054/bjoc.2000.1691 Khan, 2009, Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies, Nutr Cancer, 61, 836, 10.1080/01635580903285056 Yang, 2009, Cancer prevention by tea: animal studies, molecular mechanisms and human relevance, Nat Rev Cancer, 9, 429, 10.1038/nrc2641 Jankun, 1997, Why drinking green tea could prevent cancer, Nature, 387, 561, 10.1038/42381 Hastak, 2003, Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells, Oncogene, 22, 4851, 10.1038/sj.onc.1206708 Masuda, 2002, Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction, J Exp Ther Oncol, 2, 350, 10.1046/j.1359-4117.2002.01062.x Naksuriya, 2014, Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment, Biomaterials, 35, 3365, 10.1016/j.biomaterials.2013.12.090 Aggarwal, 2013, Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers, Br J Pharmacol, 169, 1672, 10.1111/bph.12131 Arbiser, 1998, Curcumin is an in vivo inhibitor of angiogenesis, Mol Med, 4, 376, 10.1007/BF03401744 Hong, 2006, The effects of curcumin on the invasiveness of prostate cancer in vitro and in vivo, Prostate Cancer Prostatic Dis, 9, 147, 10.1038/sj.pcan.4500856 Yoysungnoen, 2006, Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice, Clin Hemorheol Microcirc, 34, 109 Hasima, 2012, Cancer-linked targets modulated by curcumin, Int J Biochem Mol Biol, 3, 328 Shukla, 2011, Resveratrol and cellular mechanisms of cancer prevention, Ann N Y Acad Sci, 1215, 1, 10.1111/j.1749-6632.2010.05870.x Garvin, 2006, Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo, Cancer Lett, 231, 113, 10.1016/j.canlet.2005.01.031 Bishayee, 2009, Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials, Cancer Prev Res (Phila), 2, 409, 10.1158/1940-6207.CAPR-08-0160 Bishayee, 2010, Angioprevention is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis, J Carcinog Mutagen, 1 Cao, 2004, trans-3,4,5′-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells, Clin Cancer Res, 10, 5253, 10.1158/1078-0432.CCR-03-0588 Liu, 2012, Effects of resveratrol on vascular endothelial growth factor expression in osteosarcoma cells and cell proliferation, Oncol Lett, 4, 837, 10.3892/ol.2012.824 Srivastava, 2010, FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol, Mol Cell Biochem, 337, 201, 10.1007/s11010-009-0300-5 Marti-Centelles, 2013, Inhibition of VEGF expression in cancer cells and endothelial cell differentiation by synthetic stilbene derivatives, Bioorg Med Chem, 21, 3010, 10.1016/j.bmc.2013.03.072 Jung, 2011, Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells, Biol Pharm Bull, 34, 850, 10.1248/bpb.34.850 Kimura, 2008, Antitumor activities of synthetic and natural stilbenes through antiangiogenic action, Cancer Sci, 99, 2083 Fotsis, 1997, Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis, Cancer Res, 57, 2916 Fotsis, 1995, Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis, J Nutr, 125, 790S van Meeteren, 2004, Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease, Biochem Pharmacol, 67, 967, 10.1016/j.bcp.2003.10.018 Chen, 2013, A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention, Food Chem, 138, 2099, 10.1016/j.foodchem.2012.11.139 Duthie, 2000, Plant-derived phenolic antioxidants, Curr Opin Clin Nutr Metab Care, 3, 447, 10.1097/00075197-200011000-00006 Cortes, 2007, Kaempferol inhibits IL-4-induced STAT6 activation by specifically targeting JAK3, J Immunol, 179, 3881, 10.4049/jimmunol.179.6.3881 Lee, 2010, Kaempferol inhibits UVB-induced COX-2 expression by suppressing Src kinase activity, Biochem Pharmacol, 80, 2042, 10.1016/j.bcp.2010.06.042 Garcia-Mediavilla, 2007, The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells, Eur J Pharmacol, 557, 221, 10.1016/j.ejphar.2006.11.014 Suh, 2009, A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappaB-signaling pathways, Carcinogenesis, 30, 300, 10.1093/carcin/bgn269 Singh, 2003, Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis, Cancer Epidemiol Biomarkers Prev, 12, 933 Singh, 2005, Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy, Oncogene, 24, 1188, 10.1038/sj.onc.1208276 Jiang, 2000, Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells, Biochem Biophys Res Commun, 276, 371, 10.1006/bbrc.2000.3474 Tsai, 1999, Suppression of TNFalpha-mediated NFkappaB activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells, J Cell Biochem, 74, 606, 10.1002/(SICI)1097-4644(19990915)74:4<606::AID-JCB10>3.0.CO;2-W Bertl, 2006, Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention, Mol Cancer Ther, 5, 575, 10.1158/1535-7163.MCT-05-0324 Kim, 2010, Antiangiogenic effect of licochalcone A, Biochem Pharmacol, 80, 1152, 10.1016/j.bcp.2010.07.006 Kwon, 2009, Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling, J Nutr Biochem, 20, 663, 10.1016/j.jnutbio.2008.06.005 Hasmeda, 1999, Selective inhibition of eukaryote protein kinases by anti-inflammatory triterpenoids, Planta Med, 65, 14, 10.1055/s-1999-13954 Beveridge, 2002, Phytosterol content in American ginseng seed oil, J Agric Food Chem, 50, 744, 10.1021/jf010701v Thoppil, 2011, Terpenoids as potential chemopreventive and therapeutic agents in liver cancer, World J Hepatol, 3, 228, 10.4254/wjh.v3.i9.228 Bishayee, 2011, Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer, Front Biosci (Landmark Ed), 16, 980, 10.2741/3730 Sethi, 2007, Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation, Blood, 109, 2727, 10.1182/blood-2006-10-050807 Huang, 2008, Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression, Cancer Lett, 264, 101, 10.1016/j.canlet.2008.01.043 Matsuda, 1997, Effects of escins Ia, Ib, IIa, and IIb from horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals, Biol Pharm Bull, 20, 1092, 10.1248/bpb.20.1092 Wang, 2008, Effect of beta-escin sodium on endothelial cells proliferation, migration and apoptosis, Vasc Pharmacol, 49, 158, 10.1016/j.vph.2008.07.005 Yang, 2007, The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from “Indian winter cherry”, Mol Pharmacol, 71, 426, 10.1124/mol.106.030015 Mohan, 2004, Withaferin A is a potent inhibitor of angiogenesis, Angiogenesis, 7, 115, 10.1007/s10456-004-1026-3 Jayaprakasam, 2003, Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves, Life Sci, 74, 125, 10.1016/j.lfs.2003.07.007 Park, 1998, Dietary lutein from marigold extract inhibits mammary tumor development in BALB/c mice, J Nutr, 128, 1650, 10.1093/jn/128.10.1650 Krinsky, 2005, Carotenoid actions and their relation to health and disease, Mol Aspects Med, 26, 459, 10.1016/j.mam.2005.10.001 Milder, 2005, Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol, Br J Nutr, 93, 393, 10.1079/BJN20051371 Thompson, 2006, Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan, Nutr Cancer, 54, 184, 10.1207/s15327914nc5402_5 Mazur, 1996, Isotope dilution gas chromatographic-mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples, Anal Biochem, 233, 169, 10.1006/abio.1996.0025 Touillaud, 2007, Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status, J Natl Cancer Inst, 99, 475, 10.1093/jnci/djk096 Trock, 2006, Meta-analysis of soy intake and breast cancer risk, J Natl Cancer Inst, 98, 459, 10.1093/jnci/djj102 Banerjee, 2008, Multi-targeted therapy of cancer by genistein, Cancer Lett, 269, 226, 10.1016/j.canlet.2008.03.052 Helferich, 2008, Phytoestrogens and breast cancer: a complex story, Inflammopharmacology, 16, 219, 10.1007/s10787-008-8020-0 Lindahl, 2011, Tamoxifen, flaxseed, and the lignan enterolactone increase stroma- and cancer cell-derived IL-1Ra and decrease tumor angiogenesis in estrogen-dependent breast cancer, Cancer Res, 71, 51, 10.1158/0008-5472.CAN-10-2289 Bergman Jungestrom, 2007, Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo, Clin Cancer Res, 13, 1061, 10.1158/1078-0432.CCR-06-1651 Saarinen, 2010, Estrogen-induced angiogenic factors derived from stromal and cancer cells are differently regulated by enterolactone and genistein in human breast cancer in vivo, Int J Cancer, 127, 737, 10.1002/ijc.25052 Chatterjee, 2012, Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor, Bioinformation, 8, 1249, 10.6026/97320630081249 Abusnina, 2015, Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition, Thromb Haemost, 113, 319, 10.1160/TH14-05-0454 Rath, 2012, Anti-angiogenic effects of the tubulysin precursor pretubulysin and of simplified pretubulysin derivatives, Br J Pharmacol, 167, 1048, 10.1111/j.1476-5381.2012.02037.x Schluep, 2009, Polymeric tubulysin-peptide nanoparticles with potent antitumor activity, Clin Cancer Res, 15, 181, 10.1158/1078-0432.CCR-08-1848 Kubisch, 2014, Simplified pretubulysin derivatives and their biological effects on cancer cells, J Nat Prod, 77, 536, 10.1021/np4008014 Peer, 2007, Nanocarriers as an emerging platform for cancer therapy, Nat Nanotechnol, 2, 751, 10.1038/nnano.2007.387 Gref, 1994, Biodegradable long-circulating polymeric nanospheres, Science, 263, 1600, 10.1126/science.8128245 Siddiqui, 2009, Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate, Cancer Res, 69, 1712, 10.1158/0008-5472.CAN-08-3978 Luo, 2012, Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability, Int J Nanomed, 7, 3951 Gou, 2011, Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo, Nanoscale, 3, 1558, 10.1039/c0nr00758g Wang, 2014, Enhancing the antitumor activity of berberine hydrochloride by solid lipid nanoparticle encapsulation, AAPS PharmSciTech, 15, 834, 10.1208/s12249-014-0112-0 Parikh, 2014, Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives, Phytochem Rev, 13, 793, 10.1007/s11101-014-9337-5 Sohn, 1995, Anti-angiogenic activity of triterpene acids, Cancer Lett, 94, 213, 10.1016/0304-3835(95)03856-R Sogno, 2009, Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids, Recent Results Cancer Res, 181, 209, 10.1007/978-3-540-69297-3_19 Masferrer, 2000, Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors, Cancer Res, 60, 1306 Parrett, 1997, Cyclooxygenase-2 gene expression in human breast cancer, Int J Oncol, 10, 503 Voss, 2010, Tumour reactions to hypoxia, Curr Mol Med, 10, 381, 10.2174/156652410791317020 Lofstedt, 2004, Induction of ID2 expression by hypoxia-inducible factor-1: a role in dedifferentiation of hypoxic neuroblastoma cells, J Biol Chem, 279, 39223, 10.1074/jbc.M402904200 Garcia-Maceira, 2009, Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy, Oncogene, 28, 313, 10.1038/onc.2008.398 Otalora, 2008, Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice, J Pineal Res, 44, 307, 10.1111/j.1600-079X.2007.00531.x Trapp, 2010, Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture, Angiogenesis, 13, 305, 10.1007/s10456-010-9187-8 Park, 2007, Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol, Cancer Lett, 258, 63, 10.1016/j.canlet.2007.08.011 Li, 2007, Delta-like 4 notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo, Cancer Res, 67, 11244, 10.1158/0008-5472.CAN-07-0969 Lickliter, 2010, Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent, Br J Cancer, 103, 597, 10.1038/sj.bjc.6605841 Lekli, 2010, Co-ordinated autophagy with resveratrol and gamma-tocotrienol confers synergetic cardioprotection, J Cell Mol Med, 14, 2506, 10.1111/j.1582-4934.2009.00921.x Kuang, 2006, Neuroprotective role of Z-ligustilide against forebrain ischemic injury in ICR mice, Brain Res, 1102, 145, 10.1016/j.brainres.2006.04.110 Forssell, 2007, High macrophage infiltration along the tumor front correlates with improved survival in colon cancer, Clin Cancer Res, 13, 1472, 10.1158/1078-0432.CCR-06-2073 Garaude, 2012, Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses, Sci Transl Med, 4, 120ra116, 10.1126/scitranslmed.3002868 Tosetti, 2009, Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals, Int J Cancer, 125, 1997, 10.1002/ijc.24677 Deep, 2012, Angiopreventive efficacy of pure flavonolignans from milk thistle extract against prostate cancer: targeting VEGF–VEGFR signaling, PLoS ONE, 7, e34630, 10.1371/journal.pone.0034630 Surh, 2003, Cancer chemoprevention with dietary phytochemicals, Nat Rev Cancer, 3, 768, 10.1038/nrc1189 Thomasset, 2007, Dietary polyphenolic phytochemicals – promising cancer chemopreventive agents in humans? A review of their clinical properties, Int J Cancer, 120, 451, 10.1002/ijc.22419 Bisacchi, 2003, Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives, Cancer Detect Prev, 27, 229, 10.1016/S0361-090X(03)00030-8 Macpherson, 2013, Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials, Am J Clin Nutr, 97, 437, 10.3945/ajcn.112.049304 Klein, 2011, Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT), JAMA, 306, 1549, 10.1001/jama.2011.1437 Sommer, 2012, A global clinical view on vitamin A and carotenoids, Am J Clin Nutr, 96, 1204S, 10.3945/ajcn.112.034868 Yang, 2013, Anti-VEGF- and anti-VEGF receptor-induced vascular alteration in mouse healthy tissues, Proc Natl Acad Sci U S A, 110, 12018, 10.1073/pnas.1301331110 Kumareswaran, 2012, Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability, J Cell Sci, 125, 189, 10.1242/jcs.092262 Gaddameedhi, 2012, Effect of circadian clock mutations on DNA damage response in mammalian cells, Cell Cycle, 11, 3481, 10.4161/cc.21771 Dai, 2013, Tumor environmental factors glucose deprivation and lactic acidosis induce mitotic chromosomal instability – an implication in aneuploid human tumors, PLOS ONE, 8, e63054, 10.1371/journal.pone.0063054 Xiang, 2014, Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer, J Mol Med (Berl), 92, 151, 10.1007/s00109-013-1102-5 Leelahavanichkul, 2014, A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis, Mol Oncol, 8, 105, 10.1016/j.molonc.2013.10.003 Thiele, 2013, Delphinidin is a novel inhibitor of lymphangiogenesis but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats, Carcinogenesis, 34, 2804, 10.1093/carcin/bgt291 Yu, 2013, High interstitial fluid pressure promotes tumor cell proliferation and invasion in oral squamous cell carcinoma, Int J Mol Med, 32, 1093, 10.3892/ijmm.2013.1496 Hofmann, 2006, Lowering of tumor interstitial fluid pressure reduces tumor cell proliferation in a xenograft tumor model, Neoplasia, 8, 89, 10.1593/neo.05469 Rana, 2014, Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia, Mol Biol Rep, 41, 95, 10.1007/s11033-013-2841-7 Sotak, 2013, An association between clock genes and clock-controlled cell cycle genes in murine colorectal tumors, Int J Cancer, 132, 1032, 10.1002/ijc.27760 Orimo, 2005, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell, 121, 335, 10.1016/j.cell.2005.02.034 Jia, 2013, Cancer-associated fibroblasts from hepatocellular carcinoma promote malignant cell proliferation by HGF secretion, PLOS ONE, 8, e63243, 10.1371/journal.pone.0063243 Wang, 2013, Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-kappaB pathways induced by paracrine cytokines, J Exp Clin Cancer Res, 32, 51, 10.1186/1756-9966-32-51 Shi, 2013, Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature, Med Oncol, 30, 698, 10.1007/s12032-013-0698-1 Casazza, 2013, Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity, Cancer Cell, 24, 695, 10.1016/j.ccr.2013.11.007 Tripathi, 2014, Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin, Oncotarget, 5, 5350, 10.18632/oncotarget.2110 Tomei, 2009, Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment, J Immunol, 183, 4273, 10.4049/jimmunol.0900835 Mamlouk, 2013, Hypoxia-inducible factors as key regulators of tumor inflammation, Int J Cancer, 132, 2721, 10.1002/ijc.27901 Lee, 2011, Regulation of apoptosis by the circadian clock through NF-kappaB signaling, Proc Natl Acad Sci U S A, 108, 12036, 10.1073/pnas.1108125108 Erez, 2010, Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner, Cancer Cell, 17, 135, 10.1016/j.ccr.2009.12.041 Ohashi, 2013, Dichloroacetate improves immune dysfunction caused by tumor-secreted lactic acid and increases antitumor immunoreactivity, Int J Cancer, 133, 1107, 10.1002/ijc.28114 Ghajar, 2013, The perivascular niche regulates breast tumour dormancy, Nat Cell Biol, 15, 807, 10.1038/ncb2767 Gardner, 2001, Hypoxia inhibits G1/S transition through regulation of p27 expression, J Biol Chem, 276, 7919, 10.1074/jbc.M010189200 Goda, 2003, Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia, Mol Cell Biol, 23, 359, 10.1128/MCB.23.1.359-369.2003 Yamanda, 2009, Role of ephrinB2 in nonproductive angiogenesis induced by Delta-like 4 blockade, Blood, 113, 3631, 10.1182/blood-2008-07-170381 Bussink, 1998, Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts, Br J Cancer, 77, 57, 10.1038/bjc.1998.9 Rupertus, 2009, Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation, Ann Surg Oncol, 16, 2629, 10.1245/s10434-009-0564-8 Li, 2010, Cancer inhibition through circadian reprogramming of tumor transcriptome with meal timing, Cancer Res, 70, 3351, 10.1158/0008-5472.CAN-09-4235 Yang, 2008, Inhibition of casein kinase 1-epsilon induces cancer-cell-selective, PERIOD2-dependent growth arrest, Genome Biol, 9, R92, 10.1186/gb-2008-9-6-r92 Lin, 2013, Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice, Hepatology, 57, 171, 10.1002/hep.25991 Wang, 2009, Crosstalk to stromal fibroblasts induces resistance of lung cancer to epidermal growth factor receptor tyrosine kinase inhibitors, Clin Cancer Res, 15, 6630, 10.1158/1078-0432.CCR-09-1001 Pontiggia, 2012, The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through beta1 integrin, Breast Cancer Res Treat, 133, 459, 10.1007/s10549-011-1766-x Madhok, 2010, Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells, Br J Cancer, 102, 1746, 10.1038/sj.bjc.6605701 Riemann, 2011, Acidic environment leads to ROS-induced MAPK signaling in cancer cells, PLoS ONE, 6, e22445, 10.1371/journal.pone.0022445 Vangestel, 2011, (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab, J Nucl Med, 52, 1786, 10.2967/jnumed.111.092650 Hernandez-Luna, 2013, Hypoxia inducible factor-1alpha induces chemoresistance phenotype in non-Hodgkin lymphoma cell line via up-regulation of Bcl-xL, Leuk Lymphoma, 54, 1048, 10.3109/10428194.2012.733874 Islam, 2002, Hydrostatic pressure induces apoptosis in human chondrocytes from osteoarthritic cartilage through up-regulation of tumor necrosis factor-alpha, inducible nitric oxide synthase, p53, c-myc, and bax-alpha, and suppression of bcl-2, J Cell Biochem, 87, 266, 10.1002/jcb.10317 Campbell, 2010, The thrombospondin-1 mimetic ABT-510 increases the uptake and effectiveness of cisplatin and paclitaxel in a mouse model of epithelial ovarian cancer, Neoplasia, 12, 275, 10.1593/neo.91880 Hua, 2006, Circadian gene mPer2 overexpression induces cancer cell apoptosis, Cancer Sci, 97, 589, 10.1111/j.1349-7006.2006.00225.x Schafer, 2013, TGF-beta1-dependent L1CAM expression has an essential role in macrophage-induced apoptosis resistance and cell migration of human intestinal epithelial cells, Oncogene, 32, 180, 10.1038/onc.2012.44 Kinugasa, 2014, CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment, Stem Cells, 32, 145, 10.1002/stem.1556 Golding, 2013, Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy, Br J Cancer, 109, 976, 10.1038/bjc.2013.391 Nishi, 2004, Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT), Mol Cell Biol, 24, 6076, 10.1128/MCB.24.13.6076-6083.2004 Heeg, 2011, EGFR overexpression induces activation of telomerase via PI3K/AKT-mediated phosphorylation and transcriptional regulation through Hif1-alpha in a cellular model of oral-esophageal carcinogenesis, Cancer Sci, 102, 351, 10.1111/j.1349-7006.2010.01796.x Anderson, 2006, Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms, Oncogene, 25, 61, 10.1038/sj.onc.1209011 Qu, 2003, Circadian telomerase activity and DNA synthesis for timing peptide administration, Peptides, 24, 363, 10.1016/S0196-9781(03)00050-0 Qu, 2008, Telomerase reconstitution contributes to resetting of circadian rhythm in fibroblasts, Mol Cell Biochem, 313, 11, 10.1007/s11010-008-9736-2 Martinive, 2006, Preconditioning of the tumor vasculature and tumor cells by intermittent hypoxia: implications for anticancer therapies, Cancer Res, 66, 11736, 10.1158/0008-5472.CAN-06-2056 Mazzone, 2009, Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization, Cell, 136, 839, 10.1016/j.cell.2009.01.020 Kieda, 2013, Stable tumor vessel normalization with pO(2) increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment, J Mol Med (Berl), 91, 883, 10.1007/s00109-013-0992-6 Sun, 2014, Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth, Cell Metab, 19, 285, 10.1016/j.cmet.2013.11.022 Liao, 2014, Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism, PLOS ONE, 9, e84941, 10.1371/journal.pone.0084941 Lamonte, 2013, Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress, Cancer Metab, 1, 23, 10.1186/2049-3002-1-23 Matsubara, 2013, Additive influence of extracellular pH, oxygen tension, and pressure on invasiveness and survival of human osteosarcoma cells, Front Oncol, 3, 199, 10.3389/fonc.2013.00199 Kelly, 2014, Regulation of O2 consumption by the PI3K and mTOR pathways contributes to tumor hypoxia, Radiother Oncol, 111, 72, 10.1016/j.radonc.2014.02.007 Seront, 2013, Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours, Br J Cancer, 109, 2597, 10.1038/bjc.2013.644 Okazaki, 2014, Circadian regulation of mTOR by the ubiquitin pathway in renal cell carcinoma, Cancer Res, 74, 543, 10.1158/0008-5472.CAN-12-3241 Rattigan, 2012, Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment, Exp Cell Res, 318, 326, 10.1016/j.yexcr.2011.11.014 Wojtkowiak, 2012, Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments, Cancer Res, 72, 3938, 10.1158/0008-5472.CAN-11-3881 Belkin, 2013, CD200 upregulation in vascular endothelium surrounding cutaneous squamous cell carcinoma, JAMA Dermatol, 149, 178, 10.1001/jamadermatol.2013.1609 Hamzah, 2008, Vascular normalization in Rgs5-deficient tumours promotes immune destruction, Nature, 453, 410, 10.1038/nature06868 Chi Sabins, 2013, DLK1: a novel target for immunotherapeutic remodeling of the tumor blood vasculature, Mol Ther, 21, 1958, 10.1038/mt.2013.133 Garufi, 2012, Targeting COX-2/PGE(2) pathway in HIPK2 knockdown cancer cells: impact on dendritic cell maturation, PLoS ONE, 7, e48342, 10.1371/journal.pone.0048342 Deng, 2013, Intratumor hypoxia promotes immune tolerance by inducing regulatory T cells via TGF-beta1 in gastric cancer, PLOS ONE, 8, e63777, 10.1371/journal.pone.0063777 Lund, 2012, VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics, Cell Rep, 1, 191, 10.1016/j.celrep.2012.01.005 Craig, 2008, Increased pressure stimulates aberrant dendritic cell maturation, Cell Mol Biol Lett, 13, 260, 10.2478/s11658-007-0054-6 Baronzio, 2012, Tumor interstitial fluid as modulator of cancer inflammation, thrombosis, immunity and angiogenesis, Anticancer Res, 32, 405 Preise, 2011, Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP), Photochem Photobiol Sci, 10, 681, 10.1039/c0pp00315h Miyazaki, 2010, Tumor growth suppression in vivo by overexpression of the circadian component, PER2, Genes Cells, 15, 351, 10.1111/j.1365-2443.2010.01384.x Hsiao, 2013, CCAAT/enhancer binding protein delta in macrophages contributes to immunosuppression and inhibits phagocytosis in nasopharyngeal carcinoma, Sci Signal, 6, ra59, 10.1126/scisignal.2003648 Daurkin, 2011, Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway, Cancer Res, 71, 6400, 10.1158/0008-5472.CAN-11-1261 Mace, 2013, Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner, Cancer Res, 73, 3007, 10.1158/0008-5472.CAN-12-4601 Villalba, 2013, From tumor cell metabolism to tumor immune escape, Int J Biochem Cell Biol, 45, 106, 10.1016/j.biocel.2012.04.024 Chirasani, 2013, Diclofenac inhibits lactate formation and efficiently counteracts local immune suppression in a murine glioma model, Int J Cancer, 132, 843, 10.1002/ijc.27712 Calcinotto, 2012, Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes, Cancer Res, 72, 2746, 10.1158/0008-5472.CAN-11-1272 James, 1974, Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma, Cancer Res, 34, 839 Lee, 2009, Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model, Proc Natl Acad Sci U S A, 106, 19485, 10.1073/pnas.0909228106 Cao, 2005, Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis, Nat Rev Cancer, 5, 735, 10.1038/nrc1693 Lunt, 2008, Interstitial fluid pressure, vascularity and metastasis in ectopic, orthotopic and spontaneous tumours, BMC Cancer, 8, 2, 10.1186/1471-2407-8-2 Rofstad, 2002, Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts, Cancer Res, 62, 661 Yu, 2014, High interstitial fluid pressure promotes tumor progression through inducing lymphatic metastasis-related protein expressions in oral squamous cell carcinoma, Clin Transl Oncol, 16, 539, 10.1007/s12094-013-1115-0 Rofstad, 2010, Tumors exposed to acute cyclic hypoxic stress show enhanced angiogenesis, perfusion and metastatic dissemination, Int J Cancer, 127, 1535, 10.1002/ijc.25176 Oshima, 2011, Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer, Oncol Rep, 25, 1439, 10.3892/or.2011.1207 Wu, 2012, Experimental chronic jet lag promotes growth and lung metastasis of Lewis lung carcinoma in C57BL/6 mice, Oncol Rep, 27, 1417 Zhang, 2011, Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion, Cancer Lett, 303, 47, 10.1016/j.canlet.2011.01.011 Qian, 2011, CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis, Nature, 475, 222, 10.1038/nature10138 Rofstad, 2006, Acidic extracellular pH promotes experimental metastasis of human melanoma cells in athymic nude mice, Cancer Res, 66, 6699, 10.1158/0008-5472.CAN-06-0983 Peppicelli, 2014, Contribution of acidic melanoma cells undergoing epithelial-to-mesenchymal transition to aggressiveness of non-acidic melanoma cells, Clin Exp Metastasis, 31, 423, 10.1007/s10585-014-9637-6 Huang, 2012, Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy, Proc Natl Acad Sci U S A, 109, 17561, 10.1073/pnas.1215397109 Mo, 2013, Hypoxia-induced senescence contributes to the regulation of microenvironment in melanomas, Pathol Res Pract, 209, 640, 10.1016/j.prp.2013.07.004 Shin, 2009, Vascular endothelial growth factor-induced chemotaxis and IL-10 from T cells, Cell Immunol, 256, 72, 10.1016/j.cellimm.2009.01.006 Aung, 2012, Interstitial fluid pressure as an alternate regulator of angiogenesis independent of hypoxia driven HIF-1alpha in solid tumors, J Orthop Res, 30, 2038, 10.1002/jor.22154 Mao, 2012, Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3beta, Mol Endocrinol, 26, 1808, 10.1210/me.2012-1071 Kulbe, 2012, A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment, Cancer Res, 72, 66, 10.1158/0008-5472.CAN-11-2178 Dayan, 2012, Molecular crosstalk between cancer cells and tumor microenvironment components suggests potential targets for new therapeutic approaches in mobile tongue cancer, Cancer Med, 1, 128, 10.1002/cam4.24 Karagiannis, 2012, Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue, Mol Cancer Res, 10, 1403, 10.1158/1541-7786.MCR-12-0307 Estrella, 2013, Acidity generated by the tumor microenvironment drives local invasion, Cancer Res, 73, 1524, 10.1158/0008-5472.CAN-12-2796 Pratheeshkumar, 2011, Oleanolic acid induces apoptosis by modulating p53, Bax, Bcl-2 and caspase-3 gene expression and regulates the activation of transcription factors and cytokine profile in B16F, J Environ Pathol Toxicol Oncol, 30, 21, 10.1615/JEnvironPatholToxicolOncol.v30.i1.30 Roy, 2012, Silibinin prevents ultraviolet B radiation-induced epidermal damages in JB6 cells and mouse skin in a p53-GADD45alpha-dependent manner, Carcinogenesis, 33, 629, 10.1093/carcin/bgr299 Thomas, 2009, Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease, Mutat Res, 661, 25, 10.1016/j.mrfmmm.2008.10.016 Marden, 2006, Yeast-based assay for the measurement of positive and negative influences on microsatellite stability, FEMS Yeast Res, 6, 716, 10.1111/j.1567-1364.2006.00092.x Lu, 2013, Antioxidant induces DNA damage, cell death and mutagenecity in human lung and skin normal cells, Sci Rep, 3, 3169, 10.1038/srep03169 Liu, 2013, Melatonin enhances DNA repair capacity possibly by affecting genes involved in DNA damage responsive pathways, BMC Cell Biol, 14, 1, 10.1186/1471-2121-14-1 Denissova, 2012, Resveratrol protects mouse embryonic stem cells from ionizing radiation by accelerating recovery from DNA strand breakage, Carcinogenesis, 33, 149, 10.1093/carcin/bgr236 Mamede, 2013, Beyond the limits of oxygen: effects of hypoxia in a hormone-independent prostate cancer cell line, ISRN Oncol, 2013, 918207 Wu, 2011, Light at night activates IGF-1R/PDK1 signaling and accelerates tumor growth in human breast cancer xenografts, Cancer Res, 71, 2622, 10.1158/0008-5472.CAN-10-3837 Elshazley, 2012, The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma, Int J Cancer, 131, 2820, 10.1002/ijc.27598 Ryder, 2013, Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression, PLOS ONE, 8, e54302, 10.1371/journal.pone.0054302 Gershon, 2013, Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma, Cancer Metab, 1, 10.1186/2049-3002-1-2 Onodera, 2014, Increased sugar uptake promotes oncogenesis via EPAC/RAP1 and O-GlcNAc pathways, J Clin Invest, 124, 367, 10.1172/JCI63146 Tyagi, 2009, Growth inhibition and regression of lung tumors by silibinin: modulation of angiogenesis by macrophage-associated cytokines and nuclear factor-kappaB and signal transducers and activators of transcription 3, Cancer Prev Res (Phila), 2, 74, 10.1158/1940-6207.CAPR-08-0095 Lin, 2007, Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway, Clin Cancer Res, 13, 3423, 10.1158/1078-0432.CCR-06-3072 Moghaddam, 2009, Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice, Carcinogenesis, 30, 1949, 10.1093/carcin/bgp229 Mineva, 2013, Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells, PLOS ONE, 8, e73464, 10.1371/journal.pone.0073464 Surh, 2001, Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation, Mutat Res, 480–481, 243, 10.1016/S0027-5107(01)00183-X Corsini, 2010, Enterodiol and enterolactone modulate the immune response by acting on nuclear factor-kappaB (NF-kappaB) signaling, J Agric Food Chem, 58, 6678, 10.1021/jf100471n Jeong, 2014, Interferon gamma induced by resveratrol analog, HS-1793, reverses the properties of tumor associated macrophages, Int Immunopharmacol, 22, 303, 10.1016/j.intimp.2014.07.004 Salado, 2011, Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18, J Transl Med, 9, 59, 10.1186/1479-5876-9-59 Jang, 1997, Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science, 275, 218, 10.1126/science.275.5297.218 Wang, 2013, Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis, Carcinogenesis, 34, 1323, 10.1093/carcin/bgt058 Tae, 2011, 3-Oxoolean-12-en-27-oic acid inhibits the proliferation of non-small cell lung carcinoma cells by inducing cell-cycle arrest at G0/G1 phase, Anticancer Res, 31, 2179 Jiang, 2013, Celastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Met-deficient hepatocellular carcinoma in vivo, Mol Biol Rep, 40, 4203, 10.1007/s11033-013-2501-y Wang, 2012, Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90, J Cell Physiol, 227, 2196, 10.1002/jcp.22956 Ge, 2010, Celastrol causes apoptosis and cell cycle arrest in rat glioma cells, Neurol Res, 32, 94, 10.1179/016164109X12518779082273 Tyagi, 2002, Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention, Mol Cancer Ther, 1, 525 Tyagi, 2004, Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages, Carcinogenesis, 25, 1711, 10.1093/carcin/bgh180 Kaur, 2009, Silibinin suppresses growth and induces apoptotic death of human colorectal carcinoma LoVo cells in culture and tumor xenograft, Mol Cancer Ther, 8, 2366, 10.1158/1535-7163.MCT-09-0304 Agarwal, 2003, Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells, Oncogene, 22, 8271, 10.1038/sj.onc.1207158 Kang, 2014, Tetrahydrocurcumin induces G2/M cell cycle arrest and apoptosis involving p38 MAPK activation in human breast cancer cells, Food Chem Toxicol, 67, 193, 10.1016/j.fct.2014.02.024 Lim, 2014, Curcumin suppresses proliferation of colon cancer cells by targeting CDK2, Cancer Prev Res (Phila), 7, 466, 10.1158/1940-6207.CAPR-13-0387 Guo, 2013, Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor, Pharmazie, 68, 431 Mukhopadhyay, 2002, Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation, Oncogene, 21, 8852, 10.1038/sj.onc.1206048 Ahmad, 2002, Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate, Arch Biochem Biophys, 398, 125, 10.1006/abbi.2001.2704 Huh, 2004, Anticancer effects of (−)-epigallocatechin-3-gallate on ovarian carcinoma cell lines, Gynecol Oncol, 94, 760, 10.1016/j.ygyno.2004.05.031 Saldanha, 2014, Molecular mechanisms for inhibition of colon cancer cells by combined epigenetic-modulating epigallocatechin gallate and sodium butyrate, Exp Cell Res, 324, 40, 10.1016/j.yexcr.2014.01.024 Shen, 2014, Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway, Int J Oncol, 44, 791, 10.3892/ijo.2014.2251 Huang, 2013, Kaempferol induces autophagy through AMPK and AKT signaling molecules and causes G2/M arrest via downregulation of CDK1/cyclin B in SK-HEP-1 human hepatic cancer cells, Int J Oncol, 42, 2069, 10.3892/ijo.2013.1909 Xu, 2008, Kaempferol-7-O-beta-d-glucoside (KG) isolated from Smilax china L. rhizome induces G2/M phase arrest and apoptosis on HeLa cells in a p53-independent manner, Cancer Lett, 264, 229, 10.1016/j.canlet.2008.01.044 Choi, 2008, Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer MDA-MB-453 cells, Nutr Res Pract, 2, 322, 10.4162/nrp.2008.2.4.322 Casagrande, 2001, Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1, Biochem Pharmacol, 61, 1205, 10.1016/S0006-2952(01)00583-4 Hill, 2011, Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer, J Mammary Gland Biol Neoplasia, 16, 235, 10.1007/s10911-011-9222-4 McCann, 2008, Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro, Mol Nutr Food Res, 52, 567, 10.1002/mnfr.200700052 Stan, 2008, Ayurvedic medicine constituent withaferin A causes G2 and M phase cell cycle arrest in human breast cancer cells, Nutr Cancer, 60, 51, 10.1080/01635580802381477 Roy, 2013, Withaferin A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells, J Nat Prod, 76, 1909, 10.1021/np400441f Grogan, 2013, Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways, Invest New Drugs, 31, 545, 10.1007/s10637-012-9888-5 Adhami, 2001, Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells, Biochem Biophys Res Commun, 288, 579, 10.1006/bbrc.2001.5819 Wolter, 2001, Downregulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines, J Nutr, 131, 2197, 10.1093/jn/131.8.2197 Kim, 2006, Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways, Exp Dermatol, 15, 538, 10.1111/j.1600-0625.2006.00445.x Yang, 2013, Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner, PLOS ONE, 8, e70627, 10.1371/journal.pone.0070627 Tang, 2013, An evaluation of the anti-tumor efficacy of oleanolic acid-loaded PEGylated liposomes, Nanotechnology, 24, 235102, 10.1088/0957-4484/24/23/235102 Li, 2013, Oleanane-type triterpenoid saponins from the roots of Pulsatilla koreana and their apoptosis-inducing effects on HL-60 human promyelocytic leukemia cells, Arch Pharm Res, 36, 768, 10.1007/s12272-013-0042-5 Dizaji, 2012, Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line, Neurochem Res, 37, 370, 10.1007/s11064-011-0620-1 Fang, 2011, Proteomic identification of differentially expressed proteins in curcumin-treated MCF-7 cells, Phytomedicine, 18, 697, 10.1016/j.phymed.2010.11.012 Lee, 2014, The induction of heme oxygenase-1 suppresses heat shock protein 90 and the proliferation of human breast cancer cells through its byproduct carbon monoxide, Toxicol Appl Pharmacol, 274, 55, 10.1016/j.taap.2013.10.027 Martin, 2013, Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78, Br J Cancer, 109, 433, 10.1038/bjc.2013.325 Song, 2014, Kaempferol induces cell cycle arrest and apoptosis in renal cell carcinoma through EGFR/p38 signaling, Oncol Rep, 31, 1350, 10.3892/or.2014.2965 Kim, 2010, Melatonin induces apoptotic cell death via p53 in LNCaP cells, Korean J Physiol Pharmacol, 14, 365, 10.4196/kjpp.2010.14.6.365 Danbara, 2005, Enterolactone induces apoptosis and inhibits growth of Colo 201 human colon cancer cells both in vitro and in vivo, Anticancer Res, 25, 2269 Hahm, 2013, Role of mitogen-activated protein kinases and Mcl-1 in apoptosis induction by withaferin A in human breast cancer cells, Mol Carcinog, 53, 907, 10.1002/mc.22050 Wesolowska, 2010, Stilbenes as multidrug resistance modulators and apoptosis inducers in human adenocarcinoma cells, Anticancer Res, 30, 4587 Deeb, 2012, Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity, Biochem Biophys Res Commun, 422, 561, 10.1016/j.bbrc.2012.05.024 Deeb, 2013, Inhibition of telomerase activity by oleanane triterpenoid CDDO-Me in pancreatic cancer cells is ROS-dependent, Molecules, 18, 3250, 10.3390/molecules18033250 Nasiri, 2013, Curcumin and silibinin inhibit telomerase expression in T47D human breast cancer cells, Asian Pac J Cancer Prev, 14, 3449, 10.7314/APJCP.2013.14.6.3449 Ebrahimnezhad, 2013, Inhibition of hTERT gene expression by silibinin-loaded PLGA-PEG-Fe3O4 in T47D breast cancer cell line, Bioimpacts, 3, 67 Thelen, 2004, Inhibition of telomerase activity and secretion of prostate specific antigen by silibinin in prostate cancer cells, J Urol, 171, 1934, 10.1097/01.ju.0000121329.37206.1b Khaw, 2013, Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells, J Cell Biochem, 114, 1257, 10.1002/jcb.24466 Wang, 2009, Apoptosis induction effects of EGCG in laryngeal squamous cell carcinoma cells through telomerase repression, Arch Pharm Res, 32, 1263, 10.1007/s12272-009-1912-8 Sadava, 2007, The green tea polyphenol, epigallocatechin-3-gallate inhibits telomerase and induces apoptosis in drug-resistant lung cancer cells, Biochem Biophys Res Commun, 360, 233, 10.1016/j.bbrc.2007.06.030 Berletch, 2008, Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG, J Cell Biochem, 103, 509, 10.1002/jcb.21417 Martinez-Campa, 2008, Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells, Cancer Lett, 268, 272, 10.1016/j.canlet.2008.04.001 Lanzilli, 2006, Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro, Int J Oncol, 28, 641 Liu, 2014, Oleanolic acid suppresses aerobic glycolysis in cancer cells by switching pyruvate kinase type M isoforms, PLOS ONE, 9, e91606, 10.1371/journal.pone.0091606 Raina, 2013, Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries, Autophagy, 9, 697, 10.4161/auto.23960 Yousefi, 2012, Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-kappaB expressions may play an important role in silibinin-induced response, Neurochem Res, 37, 2053, 10.1007/s11064-012-0827-9 Vaughan, 2013, Tumor necrosis factor alpha induces Warburg-like metabolism and is reversed by anti-inflammatory curcumin in breast epithelial cells, Int J Cancer, 133, 2504, 10.1002/ijc.28264 Moreira, 2013, Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism, Exp Cell Res, 319, 1784, 10.1016/j.yexcr.2013.05.001 Valenti, 2013, Negative modulation of mitochondrial oxidative phosphorylation by epigallocatechin-3 gallate leads to growth arrest and apoptosis in human malignant pleural mesothelioma cells, Biochim Biophys Acta, 1832, 2085, 10.1016/j.bbadis.2013.07.014 Huang, 2009, EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells, Mol Nutr Food Res, 53, 1156, 10.1002/mnfr.200800592 Filomeni, 2010, Carcinoma cells activate AMP-activated protein kinase-dependent autophagy as survival response to kaempferol-mediated energetic impairment, Autophagy, 6, 202, 10.4161/auto.6.2.10971 Thors, 2008, Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids, Br J Pharmacol, 155, 244, 10.1038/bjp.2008.237 Wang, 2013, Elevated levels of mitochonrial respiratory complexes activities and ATP production in 17-beta-estradiol-induced prolactin-secretory tumor cells in male rats are inhibited by melatonin in vivo and in vitro, Chin Med J (Engl), 126, 4724 Sanchez-Sanchez, 2011, Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells, Free Radic Res, 45, 1333, 10.3109/10715762.2011.623700 Gonzalez, 2011, Melatonin reduces pancreatic tumor cell viability by altering mitochondrial physiology, J Pineal Res, 50, 250, 10.1111/j.1600-079X.2010.00834.x Hahm, 2013, Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model, J Natl Cancer Inst, 105, 1111, 10.1093/jnci/djt153 Hahm, 2011, Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species, PLoS ONE, 6, e23354, 10.1371/journal.pone.0023354 Malik, 2007, Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine, Apoptosis, 12, 2115, 10.1007/s10495-007-0129-x Gomez, 2013, Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase, Biochimie, 95, 1336, 10.1016/j.biochi.2013.02.013 Fouad, 2013, Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells: calorie restriction is the force to the cytotoxicity, Hum Exp Toxicol, 32, 1067, 10.1177/0960327113475679 Filomeni, 2007, trans-Resveratrol induces apoptosis in human breast cancer cells MCF-7 by the activation of MAP kinases pathways, Genes Nutr, 2, 295, 10.1007/s12263-007-0059-9 Nagaraj, 2010, Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer, Clin Cancer Res, 16, 1812, 10.1158/1078-0432.CCR-09-3272 Deng, 2009, Immunomodulatory activity of 3beta, 6beta-dihydroxyolean-12-en-27-oic acid in tumor-bearing mice, Chem Biodivers, 6, 1243, 10.1002/cbdv.200800187 Forghani, 2014, Silibinin inhibits accumulation of myeloid-derived suppressor cells and tumor growth of murine breast cancer, Cancer Med, 3, 215, 10.1002/cam4.186 Bhattacharyya, 2010, Curcumin reverses T cell-mediated adaptive immune dysfunctions in tumor-bearing hosts, Cell Mol Immunol, 7, 306, 10.1038/cmi.2010.11 Meeran, 2006, Prevention of ultraviolet radiation-induced immunosuppression by (−)-epigallocatechin-3-gallate in mice is mediated through interleukin 12-dependent DNA repair, Clin Cancer Res, 12, 2272, 10.1158/1078-0432.CCR-05-2672 Jang, 2013, Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization, BMC Cancer, 13, 421, 10.1186/1471-2407-13-421 Lissoni, 1996, Immunotherapy with subcutaneous low dose interleukin-2 plus melatonin as salvage therapy of heavily chemotherapy-pretreated ovarian cancer, Oncol Rep, 3, 947 Sinha, 2013, Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract, Cancer Immunol Immunother, 62, 1663, 10.1007/s00262-013-1470-2 Hushmendy, 2009, Select phytochemicals suppress human T-lymphocytes and mouse splenocytes suggesting their use in autoimmunity and transplantation, Nutr Res, 29, 568, 10.1016/j.nutres.2009.08.003 Wang, 2013, Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity, Nutr Res, 33, 971, 10.1016/j.nutres.2013.07.016 Yang, 2008, Resveratrol induces the suppression of tumor-derived CD4+CD25+ regulatory T cells, Int Immunopharmacol, 8, 542, 10.1016/j.intimp.2007.12.006 Deeb, 2011, Synthetic triterpenoid CDDO prevents the progression and metastasis of prostate cancer in TRAMP mice by inhibiting survival signaling, Carcinogenesis, 32, 757, 10.1093/carcin/bgr030 Guo, 2013, Oleanolic acid suppresses migration and invasion of malignant glioma cells by inactivating MAPK/ERK signaling pathway, PLOS ONE, 8, e72079, 10.1371/journal.pone.0072079 Huang, 2011, Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1alpha pathway, Int J Mol Med, 27, 407 Singh, 2008, Silibinin inhibits established prostate tumor growth, progression, invasion, and metastasis and suppresses tumor angiogenesis and epithelial–mesenchymal transition in transgenic adenocarcinoma of the mouse prostate model mice, Clin Cancer Res, 14, 7773, 10.1158/1078-0432.CCR-08-1309 Yang, 2012, Curcumin blocks small cell lung cancer cells migration, invasion, angiogenesis, cell cycle and neoplasia through Janus kinase-STAT3 signalling pathway, PLoS ONE, 7, e37960, 10.1371/journal.pone.0037960 Maruyama, 2014, (−)-Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer, Oncol Rep, 31, 625, 10.3892/or.2013.2925 Sharma, 2012, (−)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells, Asian Pac J Cancer Prev, 13, 4815, 10.7314/APJCP.2012.13.9.4815 Park, 2010, (−)-Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells, Oncol Rep, 23, 585 Astin, 2014, An in vivo antilymphatic screen in zebrafish identifies novel inhibitors of mammalian lymphangiogenesis and lymphatic-mediated metastasis, Mol Cancer Ther, 13, 2450, 10.1158/1535-7163.MCT-14-0469-T Chen, 2013, Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells, Oncol Rep, 30, 925, 10.3892/or.2013.2490 Rapozzi, 1992, Effects of melatonin administration on tumor spread in mice bearing Lewis lung carcinoma, Pharmacol Res, 25, 71, 10.1016/1043-6618(92)90545-M Cos, 1998, Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells, Cancer Res, 58, 4383 Miura, 2007, Hydroxymatairesinol and its mammalian metabolite enterolactone reduce the growth and metastasis of subcutaneous AH109A hepatomas in rats, Nutr Cancer, 58, 49, 10.1080/01635580701308133 Thaiparambil, 2011, Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation, Int J Cancer, 129, 2744, 10.1002/ijc.25938 Ji, 2013, Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway, PLOS ONE, 8, e78700, 10.1371/journal.pone.0078700 Sheth, 2012, Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway, PLoS ONE, 7, e51655, 10.1371/journal.pone.0051655 Yeh, 2013, The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation, PLOS ONE, 8, e56661, 10.1371/journal.pone.0056661 Wu, 2009, Oleanolic acid isolated from Oldenlandia diffusa exhibits a unique growth inhibitory effect against ras-transformed fibroblasts, Life Sci, 85, 113, 10.1016/j.lfs.2009.04.025 Ni, 2014, Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation, Acta Haematol, 131, 102, 10.1159/000354770 Xu, 2013, Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS, Int J Pharm, 454, 21, 10.1016/j.ijpharm.2013.06.053 Xu, 2012, Curcumin inhibits tumor proliferation induced by neutrophil elastase through the upregulation of alpha1-antitrypsin in lung cancer, Mol Oncol, 6, 405, 10.1016/j.molonc.2012.03.005 Zgheib, 2013, J Biol Chem, 288, 13378, 10.1074/jbc.M113.456533 Luo, 2008, Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids, Nutr Cancer, 60, 800, 10.1080/01635580802100851 Bandyopadhyay, 2008, Kaempferol and quercetin stimulate granulocyte-macrophage colony-stimulating factor secretion in human prostate cancer cells, Mol Cell Endocrinol, 287, 57, 10.1016/j.mce.2008.01.015 Alvarez-Garcia, 2013, Antiangiogenic effects of melatonin in endothelial cell cultures, Microvasc Res, 87, 25, 10.1016/j.mvr.2013.02.008 Szarc vel Szic, 2014, Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells, PLOS ONE, 9, e87850, 10.1371/journal.pone.0087850 Shamim, 2012, Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer, J Cell Physiol, 227, 1493, 10.1002/jcp.22865